erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- J. Pharmacol. Exp. Ther. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Van Herwaarden MA et al. | The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. | 2000 | Aliment. Pharmacol. Ther. | pmid:10759625 |
| Ramirez B and Richter JE | Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. | 1993 | Aliment. Pharmacol. Ther. | pmid:8094981 |
| Catnach SM et al. | Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. | 1993 | Aliment. Pharmacol. Ther. | pmid:8439638 |
| Russo A et al. | Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. | 2004 | Aliment. Pharmacol. Ther. | pmid:15274670 |
| Verhagen MA et al. | Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. | 1997 | Aliment. Pharmacol. Ther. | pmid:9663833 |
| Bai Y et al. | Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. | 2011 | Aliment. Pharmacol. Ther. | pmid:21615438 |
| Talley NJ et al. | Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. | 2000 | Aliment. Pharmacol. Ther. | pmid:11121915 |
| Emmanuel AV et al. | Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. | 2004 | Aliment. Pharmacol. Ther. | pmid:15023171 |
| Chen CL et al. | Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. | 2002 | Aliment. Pharmacol. Ther. | pmid:11929393 |
| Bell GD et al. | Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. | 1992 | Aliment. Pharmacol. Ther. | pmid:1486161 |
| Brand RM et al. | Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. | 1997 | Aliment. Pharmacol. Ther. | pmid:9218087 |
| Annese V et al. | Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. | 1997 | Aliment. Pharmacol. Ther. | pmid:9218089 |
| van Erpecum KJ et al. | Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. | 2000 | Aliment. Pharmacol. Ther. | pmid:10903008 |
| Minocha A et al. | Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. | 1995 | Aliment. Pharmacol. Ther. | pmid:8580273 |
| Landry C et al. | Could oral erythromycin optimize high energy continuous enteral nutrition? | 1996 | Aliment. Pharmacol. Ther. | pmid:8971296 |
| Ehrenpreis ED et al. | Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. | 1998 | Aliment. Pharmacol. Ther. | pmid:9690728 |
| Osato MS et al. | Comparative efficacy of new investigational agents against Helicobacter pylori. | 2001 | Aliment. Pharmacol. Ther. | pmid:11284777 |
| Curry JI et al. | Review article: erythromycin as a prokinetic agent in infants and children. | 2001 | Aliment. Pharmacol. Ther. | pmid:11328252 |
| Kendall BJ et al. | The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. | 1997 | Aliment. Pharmacol. Ther. | pmid:9146779 |
| Mosonyi L et al. | [Infectious and neoplastic complications in rheumatoid arthritis]. | 1974-1975 | Allerg Immunol (Leipz) | pmid:4282826 |
| Sabbah A et al. | [Cell-mediated immunity in antibiotic therapy]. | 1988 | Allerg Immunol (Paris) | pmid:3401307 |
| Sabbah A | [Teldane update. Interview with Dr. Alfred Sabbah, chief of the immuno-allergology laboratory of the C.H.U. d'Angers. Interview by Dr. Pierre Ceddaha]. | 1993 | Allerg Immunol (Paris) | pmid:8466639 |
| Wessel F | [Peri-anesthesia allergies to antibiotics]. | 1998 | Allerg Immunol (Paris) | pmid:9684043 |
| López Serrano C et al. | Urticaria from erythromycin. | 1993 Nov-Dec | Allergol Immunopathol (Madr) | pmid:7512783 |
| San Pedro de Saenz B et al. | FDE to macrolides. | 2002 | Allergy | pmid:11991294 |
| Florido Lopez JF et al. | Fixed eruption due to erythromycin. A case report. | 1991 | Allergy | pmid:1826819 |
| Adamson L and Walum E | Insulin and IGF-1 mediated inhibition of apoptosis in CHO cells grown in suspension in a protein-free medium. | 2007 | Altern Lab Anim | pmid:17650954 |
| Asnes RS and Grebin B | Practical antibiotic therapy in children. | 1973 | Am Fam Physician | pmid:4546004 |
| Snydman DR | Campylobacter Gastroenteritis. | 1982 | Am Fam Physician | pmid:7055019 |
| Miller KE | Diagnosis and treatment of Chlamydia trachomatis infection. | 2006 | Am Fam Physician | pmid:16669564 |
| McSherry JA | Mycoplasma pneumoniae infections. | 1983 | Am Fam Physician | pmid:6837403 |
| Guckian JC | Complications of antimicrobial therapy. | 1973 | Am Fam Physician | pmid:4353071 |
| Pagano JS and Sarubbi FA | Pneumonia. | 1972 | Am Fam Physician | pmid:4642154 |
| Langer R and Binnick S | Treatment of acne vulgaris. | 1979 | Am Fam Physician | pmid:157066 |
| Raz R and Bitnun S | Dilemmas of streptococcal pharyngitis. | 1987 | Am Fam Physician | pmid:3105301 |
| Stott GA | New macrolide antibiotics: clarithromycin and azithromycin. | 1992 | Am Fam Physician | pmid:1325106 |
| Constantine PA | Antibiotic therapy and serum digoxin toxicity. | 1998 | Am Fam Physician | pmid:9531908 |
| Robinson M | Prokinetic therapy for gastroesophageal reflux disease. | 1995 | Am Fam Physician | pmid:7653432 |
| Derrick CW and Dillon HC | Impetigo contagiosa. | 1971 | Am Fam Physician | pmid:5000340 |
| Winkelman L | Recommended revision to endocarditis prophylaxis. | 1991 | Am Fam Physician | pmid:1950954 |
| Kiselica D | Group A beta-hemolytic streptococcal pharyngitis: current clinical concepts. | 1994 | Am Fam Physician | pmid:8154403 |
| Syphilis--recommended treatment schedules, 1976. | 1976 | Am Fam Physician | pmid:961559 | |
| Luft FC | Antimicrobials in kidney and liver failure. | 1976 | Am Fam Physician | pmid:941822 |
| Ackley AM | Legionnaires' disease: an update. | 1981 | Am Fam Physician | pmid:7020390 |
| Johnson WT | Managing odontogenic infections. | 1984 | Am Fam Physician | pmid:6731235 |
| Gonorrhea--recommended treatment schecules, 1974. | 1975 | Am Fam Physician | pmid:123699 | |
| Culp ER | Ilosone update. | 1980 | Am Fam Physician | pmid:7377065 |
| Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. | 2012 | Am Fam Physician | pmid:22335221 | |
| Tan HH | Antibacterial therapy for acne: a guide to selection and use of systemic agents. | 2003 | Am J Clin Dermatol | pmid:12688836 |
| Taylor GA and Shalita AR | Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. | 2004 | Am J Clin Dermatol | pmid:15301572 |
| Ferguson DL et al. | Lichenoid lymphocytic vasculitis with a high component of histiocytes. Histogenetic implications in a specified clinical setting. | 1989 | Am J Dermatopathol | pmid:2729528 |
| Rosen RA | The use of antibiotics in the initial management of recent dog-bite wounds. | 1985 | Am J Emerg Med | pmid:3970747 |
| Altieri M et al. | Antibiotic prophylaxis in intraoral wounds. | 1986 | Am J Emerg Med | pmid:3096345 |
| Paris DG et al. | Torsades de pointes induced by erythromycin and terfenadine. | 1994 | Am J Emerg Med | pmid:7945604 |
| Traub SJ et al. | Use of pharmaceutical promotility agents in the treatment of body packers. | 2003 | Am J Emerg Med | pmid:14574669 |
| Parker DL et al. | Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin. | 2010 | Am J Health Syst Pharm | pmid:20044367 |
| Howard KB et al. | Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. | 1999 | Am J Health Syst Pharm | pmid:10478989 |
| Erythromycin resistance in Finland declines after reduction in macrolide use. | 1997 | Am J Health Syst Pharm | pmid:9359947 | |
| Lestico MR and Smith AD | Stevens-Johnson syndrome following erythromycin administration. | 1995 | Am J Health Syst Pharm | pmid:8528839 |
| Horn JR | Analysis of purported erythromycin-warfarin interaction. | 2010 | Am J Health Syst Pharm | pmid:20516463 |
| David LM | Phlebitis with intravenous erythromycin. | 1987 | Am J Hosp Pharm | pmid:3578303 |
| Pluta PL and Morgan PK | Stability of erythromycin in intravenous admixtures. | 1986 | Am J Hosp Pharm | pmid:3799601 |
| Meade RH | Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of erythromycin and its derivatives. | 1979 | Am J Hosp Pharm | pmid:386785 |
| Pinchiera JC et al. | Effect of bariatric surgery on erythromycin absorption. | 1981 | Am J Hosp Pharm | pmid:7211889 |
| Dombrower P | Intravenous erythromycin dosages. | 1979 | Am J Hosp Pharm | pmid:525638 |
| Williams KG | Pharmacists' duty to warn of drug interactions. Dooley v. Everett. | 1992 | Am J Hosp Pharm | pmid:1471651 |
| Garrison TJ and Kleinschmidt M | Other views on erythromycin selection. | 1981 | Am J Hosp Pharm | pmid:7258211 |
| Kistler SB and Kough RH | Antibiotic acquistions in a 387-bed general hospital during 1960, 1965, 1967 and 1968. | 1969 | Am J Hosp Pharm | pmid:4313068 |
| Higgin CR and Mazur MS | Prepacking unit dose erythromycin ophthalmic ointment. | 1984 | Am J Hosp Pharm | pmid:6465146 |
| Bergstrom RF and Fites AL | Letter: Stability of erythromycin gluceptate in sodium chloride injection and dextrose injection. | 1975 | Am J Hosp Pharm | pmid:237418 |
| LeBel M | Risk-benefit equation for erythromycin estolate. | 1980 | Am J Hosp Pharm | pmid:7361788 |
| O'Brien TE | Excretion of drugs in human milk. | 1974 | Am J Hosp Pharm | pmid:4608122 |
| WEISS E and DRESSLER HR | Selection of an erythromycin-resistant strain of Rickettsia prowazekii. | 1960 | Am J Hyg | pmid:13843711 |
| Lee WS | Disc sentitivity as a diagnostic aid in the identification of group D enterococci. | 1972 | Am J Med Technol | pmid:4490310 |
| Hansen JL and Swanson LN | Case study: Drug interference in clinical chemistry. | 1981 | Am J Med Technol | pmid:7223765 |
| Bauer AW | The decline of antibiotic resistance of Staphylococcus aureus isolated in the community. | 1971 | Am J Med Technol | pmid:5206836 |
| Dietz CC et al. | Double-gradient plate susceptibility testing of an Enterococcus and its L-form. | 1973 | Am J Med Technol | pmid:4701052 |
| Lilley LL and Guanci R | Drug interaction triggers weakness. | 1998 | Am J Nurs | pmid:9556673 |
| New antibiotics look good against M. avium. | 1992 | Am J Nurs | pmid:1309625 | |
| Devereux PM and Goldstein EJ | Legionnaires' disease: finding answers to the riddle. | 1980 | Am J Nurs | pmid:6898101 |
| Erythromycin use linked to pyloric stenosis. | 2000 | Am J Nurs | pmid:10738394 | |
| Koegel L | Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erythromycin, and cisplatinum. | 1985 | Am J Otol | pmid:3872601 |
| Sacristán JA et al. | Ototoxicity of erythromycin in man: electrophysiologic approach. | 1993 | Am J Otol | pmid:8503495 |
| Kyrmizakis DE et al. | QT prolongation and torsades de pointes associated with concurrent use of cisapride and erythromycin. | 2002 Sep-Oct | Am J Otolaryngol | pmid:12239699 |
| Ghidini A et al. | Successful outcome after antibiotic treatment of postamniocentesis membrane rupture and chorioamnionitis in multiple pregnancy. | 1999 | Am J Perinatol | pmid:10772199 |
| Bar J et al. | Effect of antibiotic therapy in preterm premature rupture of the membranes on neonatal mortality and morbidity. | 2000 | Am J Perinatol | pmid:11110340 |
| Ogasawara KK and Goodwin TM | The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum. | 1997 | Am J Perinatol | pmid:9259934 |
| El Younis CM et al. | Rapid marked response of severe hyperemesis gravidarum to oral erythromycin. | 1998 | Am J Perinatol | pmid:9890250 |
| Crum NF et al. | Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. | 2003 | Am J Prev Med | pmid:12880877 |
| Usiskin SI et al. | Retreatment with clozapine after erythromycin-induced neutropenia. | 2000 | Am J Psychiatry | pmid:10831491 |
| Funderburg LG et al. | Seizure following addition of erythromycin to clozapine treatment. | 1994 | Am J Psychiatry | pmid:7977898 |
| Fox KK et al. | Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. | 2001 | Am J Public Health | pmid:11392941 |
| Tsevat J et al. | Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. | 1989 | Am J Public Health | pmid:2499200 |
| Park HH et al. | The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. | 2010 Sep-Oct | Am J Rhinol Allergy | pmid:21244734 |
| Jiang RS et al. | Efficacy of Chinese herbal medicine compared with a macrolide in the treatment of chronic rhinosinusitis without nasal polyps. | 2012 Jul-Aug | Am J Rhinol Allergy | pmid:22801017 |
| RUBIN A et al. | The effects of the administration of erythromycin upon Neisseria gonorrhoeae and pleuropneumonia-like organisms in the uterine cervix. | 1954 | Am J Syph Gonorrhea Vener Dis | pmid:13189043 |
| GABLE GR et al. | Treatment of gonorrhea with erythromycin. | 1953 | Am J Syph Gonorrhea Vener Dis | pmid:13065617 |
| ALEXANDER LJ and SCHOCH AG | Erythromycin in venereal diseases. | 1954 | Am J Syph Gonorrhea Vener Dis | pmid:13138815 |
| MANNING PR et al. | Erythromycin in the treatment of gonorrhea. | 1954 | Am J Syph Gonorrhea Vener Dis | pmid:13138816 |
| Bachmann K et al. | A study of the interaction between dirithromycin and astemizole in healthy adults. | 1997 Feb-Mar | Am J Ther | pmid:10423595 |